273
Views
9
CrossRef citations to date
0
Altmetric
HEMATOLOGY

Comparative Assessment of Deferiprone and Deferasirox in Thalassemia Major Patients in the First Two Decades-Single Centre Experience

, , , , &
Pages 104-112 | Received 15 Oct 2012, Accepted 22 Dec 2012, Published online: 30 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Adriana Ceci, Rosa Conte, Antonella Didio, Donato Bonifazi, Mariagrazia Felisi, Viviana Giannuzzi & Fedele Bonifazi. (2019) An overview of the efficacy and safety of deferiprone in paediatric patients with congenital haemoglobinopathies and chronic iron overload. Expert Opinion on Orphan Drugs 7:4, pages 181-197.
Read now

Articles from other publishers (8)

Andreas Budi WijayaWulandewi MarhaeniTriawanti TriawantiWivina Riza DeviMaulana SaputraGalih Rahman. (2023) Oxidative Stress and Renal Function in Pediatric Patients with Beta Thalassemia Major (β-TM) Receiving Deferiprone and Deferasirox: A Cross-Sectional, Single Center Study. Research Journal of Pharmacy and Technology, pages 1225-1230.
Crossref
Arisha Saleem, Eisha Waqar, Syed Hasan Shuja, Unaiza Naeem, Abdul Moeed, Heena Rais & Jawad Ahmed. (2023) No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis. Transfusion Clinique et Biologique 30:1, pages 69-74.
Crossref
Rabah Almahmoud, Amal Hussein, Fatheya Al Khaja, AhmedFarrag Soliman, Hany Dewedar & Sarah Mathai. (2022) Demographic and clinical profiles of patients with β-thalassemia major treated at Dubai Thalassemia Centre: A retrospective study. Advances in Biomedical and Health Sciences 1:4, pages 237.
Crossref
Ruslan Cusnir, Cinzia Imberti, Robert Hider, Philip Blower & Michelle Ma. (2017) Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68. International Journal of Molecular Sciences 18:1, pages 116.
Crossref
Weerapon Sangartit, Poungrat Pakdeechote, Veerapol Kukongviriyapan, Wanida Donpunha, Shigeki Shibahara & Upa Kukongviriyapan. (2016) Tetrahydrocurcumin in combination with deferiprone attenuates hypertension, vascular dysfunction, baroreflex dysfunction, and oxidative stress in iron-overloaded mice. Vascular Pharmacology 87, pages 199-208.
Crossref
Salah Mohamed El Sayed, Ashraf Abou-Taleb, Hany Salah Mahmoud, Hussam Baghdadi, Reham A. Maria, Nagwa Sayed Ahmed & Manal Mohamed Helmy Nabo. (2014) Percutaneous excretion of iron and ferritin (through Al-hijamah) as a novel treatment for iron overload in beta-thalassemia major, hemochromatosis and sideroblastic anemia. Medical Hypotheses 83:2, pages 238-246.
Crossref
. (2014) Deferasirox. Reactions Weekly 1493:1, pages 20-20.
Crossref
Jaroslav Cermak, Anna Jonasova, Jana Vondrakova, Libor Cervinek, Petra Belohlavkova & Radana Neuwirtova. (2013) A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes. Leukemia Research 37:12, pages 1612-1615.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.